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Introduction
Early onset of juvenile idiopathic arthritis (eoJIA) asso-
ciated with pauci?polyarthicular joints involvement, anti-
nuclear factor and uveitis is a special subtype of JIA.
Generally accepted opinion of pediatric rheumatologists
this JIA category isn`t belong to ankylosing spondylitis
(AS)-related group of diseases.
Objectives
To present clinical observation of a family case (mother
and daughter) of eoJIA with uveitis, homogenous clinical
picture in the disease beginning and manifestation of




Female patient was born in 1978. Disease onset was
reported when she was 3 years old from arthritis of right
knee and developed polyarthritis within 2 years. By the
3rd year of disease duration bilateral uveitis involved. She
was rtreated by NSAIDs treatment, intra-articular gluco-
corticoid (GC) injections, and different (>5) DMARDs
consequently; multiple courses of GC pulse therapy, local
ocular therapy and repeated surgical treatment of ocular
complications, since 1996 - prednisolone (10 mg/day)
continuously. Despite the treatment, polyarthritis and
hight activity persisted, corneal spot developed. Signifi-
cant aggravation was reported after the first labors (age
22 years); inflammatory back pain appeared. Ankylosis of
neck and sacroiliac joints, osteonecrosis of left femoral
head were observed. ive. AS (HLA-B27-negative) was
diagnosed after 20 years of disease duration. In 2004 hip
replacement of left femoral joint performed. In 2009 after
2nd labors disease progression with high activity and
osteonecrosis of right femoral joint developed, that
required hip replacement. High activity persisted within
next 4 years until adalimumab (ADA) therapy was
started. Her daughter, which was born in 2009, developed
oligoarthritis in the age of 2. Despite of therapy with
NSAIDs, SSZ, i.a. GC injections arthritis was extended to
polyarthritis with dactylitis of 3rd fingers of hands and
flexor contracture of knee joints. Bilateral uveitis was
diagnosed and local eye treatment was initiated. MTX (s/
c 12 mg/m2/week) was added to SSZ treatment. 4
months later cyclosporine A prescribed instead of SSZ,
repeated i.a.GC injections were needed. ESR was
30 mm/h, C-reactive protein - 52.3 mg/l, HLA-B27 –
negative, ANF positive (1/320). Hypertrophy of meta-
physes on separate phalanxes by X-ray, bone marrow
edema and synovitis of some hand`s fingers by MRA
observed. In 2013 ADA was not approved for children
younger 4th in Russia. Considering the progression of
clinical and functional disorders, local growth distuban-
ceas, periostitis, persistence of active uveitis, and bad out-
come of the similar disease in her mother ADA 30 mg s/c
once in 2 weeks was added to MTX. Initial effect was
good for the arthritis and uveitis; but later, within the
next 2 months the efficacy level has somewhat decreased.
ADA was increased up to 40 mg per injection with
achievement of clinical remission by 1 year of therapy
without any adverse event. ADA therapy started in her
mother (1st pt) in the same time with good respond.
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Conclusion
This clinical case demonstrates the same type disease in
mother and daughter. It illustrates the possibility of AS
development in female patients with eoJIA with ANA-
associated severe uveitis, despite of HLA B27 negativity.
Aggressive treatment strategy, including ADA in a very
young patient, dose escalation ADA, seems to be justi-
fied in the case of high risk of unfavorable prognosis in
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